Anxiolytic-like action of orally administered dl-tetrahydropalmatine in elevated plus-maze

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 27, Issue 5, 2003, Pages 775-779

  Leung, Wai Chung ^a   Zheng, Hui ^a   Huen, Michael ^a   Law, Sek Lun ^a   Xue, Hong ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Anxiolytic effect; Corydalis yanhusuo W.T. Wang; dl Tetrahydropalmatine; Hypnotic effect; Isoquinoline alkaloid; Sedative effect

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALKALOID; ANXIOLYTIC AGENT; DEXTRO,LEVO TETRAHYDROPALMATINE; FLUMAZENIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL TEST; FEMALE; LOW DRUG DOSE; MALE; MAZE TEST; MOUSE; MUSCLE RELAXATION; NONHUMAN; SEDATION; TRANQUILIZING ACTIVITY;

EID: 0041630968     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(03)00108-8     Document Type: Article

References (29)

1. Bonetti E.P., Pieri L., Cumin R., Schaffner R., Pieri M., Gamzu E.R., Muller R.K., Haefely W. Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology. 78:1982;8-18.
2. Chang C.K., Lin M.T. DL-Tetrahydropalmatine may act through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats. Neurosci. Lett. 307:2001;163-166.
3. Chueh F.Y., Hsieh M.T., Chen C.F., Lin M.T. Hypotensive and bradycardic effects of dl-tetrahydropalmatine mediated by decrease in hypothalamic serotonin release in the rat. Jpn. J. Pharmacol. 69:1995;177-180.
4. File S.E., Pellow S. The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard. Br. J. Pharmacol. 86:1985;729-735.
5. File S.E., Pellow S. Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology. 88:1986;1-11.
6. File S.E., Wardill A.G. The reliability of the hole-board apparatus. Psychopharmacologia. 44:1975;47-51.
7. File S.E., Wardill A.G. Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacologia. 44:1975;53-59.
8. Finlay J.M., Damsma G., Fibiger H.C. Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration. Psychopharmacology. 106:1992;202-208.
9. Hsieh M.T., Peng W.H., Hsieh C.C. Effects of DL-tetrahydropalmatine on motor activity and the brain monoamine concentration in rats. Chin. J. Physiol. 37:1994;79-82.
10. Hsu B., Kin K.C. Pharmacological study of tetrahydropalmatine and its analogs, a new type of central depressants. Arch. Int. Pharmacodyn. CXXXIX:1962;318-327.
11. Huang T.K. Handbook of the Composition and Pharmacology of Common Chinese Drugs. 1994;Chung-kuo i yao ko chi chu pan she, Beijing.
12. Jin G.Z., Xu S.X., Yu L.P. Different effects of enantiomers of tetrahydropalmatine on dopaminergic system. Scient. Sin. Ser. B. Chem. Biol., Agric., Med. Earth Sci. 29:1986;1054-1064.
13. Kaneko H., Naruto S. Studies on the constituents of Corydalis sp.: VI. Alkaloids from Chinese Corydalis and the identity of d-corydalmine with d-corybulbine. J. Org. Chem. 34:1969;2803-2805.
14. Kubo M., Matsuda H., Tokuoka K., Ma S., Shiomoto H. Anti-inflammatory activities of methanolic extract and alkaloidal components from Corydalis tuber. Biol. Pharm. Bull. 17:1994;262-265.
15. Likhitwitayawuid K., Ruangrungsi N., Cordell G.A. 1H and 13C NMR assignments of isoquinoline alkaloids, J. Sci. Soc. Thail. 19:1993;87-96.
16. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
17. Liu G.Q., Algeri S., Garattini S. DL-Tetrahydropalmatine as monoamine depletor. Arch. Int. Pharmacodyn. Ther. 258:1982;39-50.
18. Matsuda H., Shiomoto H., Naruto S., Namba K., Kubo M. Anti-thrombic action of methanol extract and alkaloidal components from Corydalis tuber. Planta Med. 54:1988;27-33.
19. Motzo C., Porceddu M.L., Dazzi L., Sanna A., Serra M., Biggio G.E. Enhancement by flumazenil of dopamine release in the nucleus accumbens of rats repeatedly exposed to diazepam or imidazenil. Psychopharmacology. 131:1997;34-39.
20. Narasimhan N.S., Bhide B.H. A novel synthesis of tetrahydropalmatine. Chem. Ind. 19:1969;621-622.
21. Nolan N.A., Parkes M.W. The effects of benzodiazepines on the behaviour of mice on a hole-board. Psychopharmacologia. 29:1973;277-286.
22. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24:1986;525-529.
23. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
24. Ribar B. Structure of (±)-tetrahydropalmatine. Acta Crystallogr. C49:1993;1961-1963.
25. Sun B.C., Huang K.X., Jin G.Z. Comparison of effects of tetrahydropalmatine enantiomers on firing activity of dopamine neurons in substantia nigra pars compacta. Acta Pharmacol. Sin. 13:1992;292-297.
26. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44:1993;463-469.
27. Trevitt T., Carlson B., Correa M., Keene A., Morales M., Salamone D. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies. Psychopharmacology. 159:2002;229-237.
28. Xu S.X., Jin G.Z., Yu L.P., Liu G.X., Lu W.W., Fang S.D. Brain dopamine depleted by d-tetrahydropalmatine. Acta Pharm. Sin. 8:1987;207-212.
29. Zhao D.K., Zhao G.S., Qiu P.L. Effects of dl-tetrahydropalmatine on contractions of rabbit aortic strips. Acta Pharm. Sin. 9:1988;153-155.